---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-23-000044"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T03:03:33.451472+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho Q2 revenue $665M, GAAP loss $(0.80)/share, adj. EPS $0.26; respiratory revenue down 74%

## Summary
- Revenue $665.1M (+8% reported) but down 26% on supplemental combined basis vs Q2 2022.
- GAAP diluted loss per share $(0.80); adjusted EPS $0.26 vs $2.12 supplemental combined prior year.
- Non-respiratory revenue +3% supplemental combined; Labs unit +9% constant currency; respiratory -74%.
- Paid down $72M on Term Loan (excess $20M) and final $40M for Alere Cardiometabolic acquisition.
- Completed Savanna EUA and 510(k) FDA submissions as planned.

## SEC filing metadata
- accession: 0001906324-23-000044
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632423000044/0001906324-23-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632423000044/qdel-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-23-000044
- JSON: https://secwatch.observer/filing/0001906324-23-000044.json
- Plain text: https://secwatch.observer/filing/0001906324-23-000044.txt

## Key facts
- Earnings Releases
  QuidelOrtho Corp reported the second quarter ended July 2, 2023 results: revenue $665.1 million.
  - Period: the second quarter ended July 2, 2023
  - Revenue: $665.1 million
  - Result: reported results
  source text: today announced financial results for the second quarter ended July 2, 2023. The Company reported total revenue for the second quarter of 2023 of $665.1 million, compared to $613.4 million for the second quarter of 2022. GAAP diluted loss per share (LPS) for the second quarter of 2023 decreased to $(0.80), compared to diluted EPS of $0.36 for the second quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1906324/000190632423000044/0001906324-23-000044-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.